Not cancer · Austria
Alzheimer disease
How is it diagnosed today? There is no simple, reliable test. The doctor checks your general health, may order blood tests and ask about your medicines to rule out other causes, and asks you to do some memory and thinking tasks. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.5 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Symptom medicines (e.g. donepezil) plus support. NHS
5 medicines are approved for this disease in Austria:
- Donanemab (Kisunla) – approved in 2025
- Lecanemab (Leqembi) – approved in 2025
- Memantine (Memantine Mylan, Memantine ratiopharm, memantine hydrochloride) – approved in 2013
- Memantine hydrochloride (Memantine Merz) – approved in 2012
- Rivastigmine (Rivastigmine, Exelon, Exelon Patch) – approved in 2009
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (7)
- Benzgalantamine (Zunveyl) – approved for it in the US
- Brexpiprazole (Rexulti) – approved for it in the US
- Dextromethorphan and bupropion (Auvelity) – approved for it in the US
- Donepezil (Aricept, Donepezil Sandoz) – approved for it in the US, Switzerland, and France
- Galantamine (Galantamine, Reminyl PR, Galantamine Biogaran Lp) – approved for it in the US, Switzerland, and France
- Memantine and donepezil (Namzaric) – approved for it in the US
- Risperidone (Risperdal, Risperidone Eg) – approved for it in France
Being tested in people
5 open trials in Austria, 624 worldwide. See the trials
- ACP-204 (Phase 3)
- AR1001 (Phase 3)
- Atomoxetine (Phase 3)
- buntanetap/posiphen (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 3 were in animals and 0 in the lab. See them
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Mistletoe extract (only single reports in people)
- Hyperthermia (animal studies only)
- Ivermectin (animal studies only)
- Dichloroacetate (DCA) (lab studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
0 open trials in Austria with these filters
We found no open trial in Austria with these filters.
Available abroad (46 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Observes safety of Leqembi in UK people with Alzheimer's disease
NCT07781345 · ClinicalTrials.gov
Countries: United Kingdom
- Edinburgh, United Kingdom – Scottish Brain Sciences
- London, United Kingdom – Recognition Health Limited
- Motherwell, United Kingdom – Neuroclnx
No age limit given in the registry
Contact the trial teamTests neck lymph drainage surgery in people with Alzheimer's disease
NCT07854327 · ClinicalTrials.gov
Countries: Italy
- Siena, Italy – Azienda Ospedaliera Universitaria Le Scotte
No age limit given in the registry
Contact the trial teamTracking Early Markers of Progression in Neurodegenerative Diseases
NCT06596746 · ClinicalTrials.gov
Countries: Italy
- Cassino, Italy – San Raffaele Cassino
Age 10 and over
Contact the trial teamTracing how brain fluid drains to neck lymph nodes in organ donors
NCT07682155 · ClinicalTrials.gov
Countries: Spain
- Badalona, Spain – Germans Trias i Pujol Universitary Hospital
No age limit given in the registry
Contact the trial teamFollowing people with mild memory problems or dementia and their family caregivers in Bavaria
NCT07721701 · ClinicalTrials.gov
Countries: Germany
- Aschaffenburg, Germany – Klinikum Aschaffenburg-Alzenau
- Bad Aibling, Germany – Schön Klinik Bad Aibling
- Bad Neustadt an der Saale, Germany – RHÖN-KLINIKUM Campus Bad Neustadt
No age limit given in the registry
Contact the trial teamComparing a new high-detail brain PET scanner with standard PET/CT scans
NCT07595666 · ClinicalTrials.gov
Countries: Belgium
- Leuven, Belgium – UZ Leuven
Age 0 and over
Contact the trial teamTests blood markers for diagnosing memory and thinking diseases
NCT06122415 · ClinicalTrials.gov
Countries: Sweden
- Malmö, Sweden – Skåne University Hospital
No age limit given in the registry
Contact the trial teamTests a new tool for judging time perception in people with Alzheimer's disease
NCT07341009 · ClinicalTrials.gov
Countries: France
- Caen, France – Caen Hospital, neurology Unit
No age limit given in the registry
Contact the trial teamPositive psychology program for older adults with early memory and thinking decline
NCT07289061 · ClinicalTrials.gov
Countries: Greece
- Thessaloniki, Greece – Aristotle University of Thessaloniki
No age limit given in the registry
Contact the trial teamTests gum treatment in people with Alzheimer disease and gum disease
NCT07233512 · ClinicalTrials.gov
Countries: Belgium
- Liège, Belgium – CHU de Liège, Université de Liège Domaine du Sart Tilman
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamFactors linked to memory test scores and decline in Alzheimer's disease
NCT07122856 · ClinicalTrials.gov
Countries: France
- Gonesse, France – Centre Hospitalier de Gonesse
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests video-game exercise for people with dementia in long-term care
NCT06631742 · ClinicalTrials.gov
Countries: Switzerland
- Wetzikon, Switzerland – Sonnweid AG
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStoring spinal fluid samples to find new Alzheimer's disease markers
NCT03621839 · ClinicalTrials.gov
Countries: France
- Nancy, France – CHRU de Nancy
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests GnRH therapy on thinking skills in people with Down syndrome
NCT04390646 · ClinicalTrials.gov
Countries: Switzerland
- Lausanne, Switzerland – Centre Hospitalier Universitaire Vaudois (CHUV)
Ages 16 to 50
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamAnalyzes spinal fluid markers to help diagnose several brain diseases
NCT04844060 · ClinicalTrials.gov
Countries: France
- Strasbourg, France – Service d'évaluation et Centre Mémoire de Ressources et de Recherche (CM2R), Hôpital de jour Saint François - Pôle de Gériatrie, Hôpitaux Universitaires de Strasbourg, Hôpital de la Robertsau
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamSafety of LEQEMBI in People With Alzheimer's Disease in Everyday Care
NCT07762092 · ClinicalTrials.gov
Countries: Canada
- Calgary, Canada – University of Calgary - Hotchkiss Brain Institute
- Edmonton, Canada – University of Alberta, Geriatric Division
- Gatineau, Canada – Clinique Neuro-Outaouais
No age limit given in the registry
Contact the trial teamAt-Home Magnetic Therapy for Thinking and Memory Problems After Brain Injury
NCT07600320 · ClinicalTrials.gov
Countries: United States
- New York, United States – The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)
Age 16 and over
Contact the trial teamRegistry collecting health and immune data from Middle Eastern, North African and Levantine people
NCT07892651 · ClinicalTrials.gov
Countries: Jordan
- Amman, Jordan – Biosenses
No age limit given in the registry
Contact the trial teamObserves brexpiprazole safety in people with Alzheimer's dementia
NCT06875986 · ClinicalTrials.gov
Countries: Japan
- Osaka, Japan – Pharmacovigilance Department
Age 15 and over
Contact the trial teamSafety of LEQEMBI in people with Alzheimer's disease in Taiwan
NCT07869264 · ClinicalTrials.gov
Countries: Taiwan
- Kaohsiung City, Taiwan – Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital
- New Taipei City, Taiwan – Cardinal Tien Hospital
- New Taipei City, Taiwan – Far Eastern Memorial Hospital
No age limit given in the registry
Contact the trial teamLecanemab in people with early Alzheimer's disease in Canada
NCT07864623 · ClinicalTrials.gov
Countries: United States
- Nutley, United States – hospital not given
No age limit given in the registry
Contact the trial teamLithium orotate compared with placebo in early Alzheimer's disease
NCT07459959 · ClinicalTrials.gov
No age limit given in the registry
Contact the trial teamFollowing people in China with memory problems and mood disorders over time
NCT07833267 · ClinicalTrials.gov
Countries: China
- Beijing, China – Xuanwu Hospital
No age limit given in the registry
Contact the trial teamLong-term safety of lecanemab in people with Alzheimer's disease in everyday care
NCT07821658 · ClinicalTrials.gov
Countries: United States
- Nutley, United States – hospital not given
No age limit given in the registry
Contact the trial teamCompares home and lab sleep tests for breathing pauses in people with memory disorders
NCT04335994 · ClinicalTrials.gov
Countries: Canada
- Toronto, Canada – Sunnybrook Health Sciences Centre
No age limit given in the registry
Contact the trial teamWearable light device for sleep and daily rhythm problems in Alzheimer's
NCT07222449 · ClinicalTrials.gov
Countries: Taiwan
- Beigang, Taiwan – China Medical University Beigang Hospital
No age limit given in the registry
Contact the trial teamTests magnetic brain stimulation for apathy in people with memory and thinking disorders
NCT05561205 · ClinicalTrials.gov
Countries: Canada
- Toronto, Canada – Sunnybrook Health Sciences Centre
No age limit given in the registry
Contact the trial teamObserves people receiving nasal exosome or stem cell treatment for brain conditions
NCT07521384 · ClinicalTrials.gov
Countries: Mexico
- Monterrey, Mexico – Stem Solutions
Ages 4 to 80
Contact the trial teamProgram Supporting Family Caregivers of Home Health Patients With Dementia
NCT06860035 · ClinicalTrials.gov
Countries: United States
- New York, United States – VNS Health Home Care
No age limit given in the registry
Contact the trial teamWearable Watch and Light Therapy Glasses for Alzheimer's Dementia in Rural Taiwan
NCT07249918 · ClinicalTrials.gov
Countries: Taiwan
- Beigang, Taiwan – China Medical University Beigang Hospital
No age limit given in the registry
Contact the trial teamMeasuring a Blood Marker of Alzheimer's in Donated Blood
NCT07157839 · ClinicalTrials.gov
Countries: United States
- Houston, United States – University of Texas Health Science Center at Houston
No age limit given in the registry
Contact the trial teamBrain Stimulation and Methylphenidate for Apathy in Alzheimer's Disease
NCT07279740 · ClinicalTrials.gov
Countries: Canada
- Toronto, Canada – Sunnybrook Research Institute
No age limit given in the registry
Contact the trial teamStudies how family caregivers of people with Alzheimer's disease experience caregiving and bereavement
NCT07251738 · ClinicalTrials.gov
No age limit given in the registry
Contact the trial teamSpeech therapy with home brain stimulation for primary progressive aphasia
NCT05901233 · ClinicalTrials.gov
Countries: United States
- Austin, United States – University of Texas
- San Francisco, United States – Memory and Aging Center, University of California, San Francisco
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamFollows people with early Alzheimer's disease treated with lecanemab
NCT06741553 · ClinicalTrials.gov
Countries: China
- Hangzhou, China – Affiliated Hospital, School of Medicine, Zhejiang University, China
Up to age 85
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudies memory and thinking changes in people with prediabetes or type 2 diabetes
NCT05704309 · ClinicalTrials.gov
Countries: United States
- Albuquerque, United States – University of New Mexico
- Alhambra, United States – University of California Los Angeles
- Aurora, United States – University of Colorado
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests semaglutide for memory decline in people with Alzheimer's disease
NCT07135245 · ClinicalTrials.gov
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamUses AI to study signs of Parkinson and Alzheimer disease in older adults
NCT06295263 · ClinicalTrials.gov
Countries: China
- Jinan, China – Qilu Hospital of Shandong University
Ages 8 to 100
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamCollects body cell samples from people with neurological diseases for research
NCT06203106 · ClinicalTrials.gov
Countries: United States
- New York, United States – New York Stem Cell Foundation Research Institute
Age 0 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamNursing Support for People with Alzheimer's Disease During PET/CT Scans
NCT06784830 · ClinicalTrials.gov
Countries: China
- Chengdu, China – Departments of Nuclear Medicine, Sichuan Provincial People's Hospital
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
Showing 40 of 46. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- In animalsA Mito-CoQ10-TPP Nanocarrier Hybrid Enhances the Therapeutic Efficacy of Mitochondrial Transplantation in Alzheimer's Disease.ACS Chem Neurosci · 2026-11-18
- In animalsGalectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing.Proc Natl Acad Sci U S A · 2026-11-18
- In peopleThirteen-month real-world effectiveness and safety of lecanemab in Chinese patients with Alzheimer's disease: integrating objective clinical outcomes and caregiver-reported experiences.J Neurol · 2026-11-18
- ReviewDistinguishing Major Forms of Dementia Through Neuropsychological Performances: A Systematic Review With Structured Narrative Synthesis.J Geriatr Psychiatry Neurol · 2026-11-18
- In animalsAβ Aggregate-Gated Ratiometric Probe Reveals Peri-Plaque Acidification Arising from Lysosomal Dysfunction in Alzheimer's Disease.ACS Chem Neurosci · 2026-11-18
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Alzheimer Austria
Self-help organisation for 35+ years: free confidential counselling by appointment (alzheimeraustria@aon.at), young-onset group, peer counselling, partner and adult-children groups, Alzheimer Cafe, carer course.
- Demenz Selbsthilfe Austria
Federation and umbrella organisation of dementia self-help groups in Austria (founded 2021); Alzheimer Europe full member.
- Demenzstrategie „Gut leben mit Demenz“
Public portal of Austria's national dementia strategy with material for people with dementia and relatives and links to regional services.
- Fonds Demenzhilfe Österreich (Volkshilfe Demenzhilfe)
Volkshilfe initiative giving financial aid to people with dementia at risk of poverty; information on counselling, self-help groups and care services.
- MAS Alzheimerhilfe
Dementia service points (information and practical help for people with dementia and relatives), guided self-help groups, Alzheimer holiday for couples, carer tips.
Phone: +43 6132 214 10
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (9)
- Alzheimer Europe
Umbrella of national Alzheimer associations in 39 countries, with a member directory.
- Alzheimer's Association
Free 24/7 Helpline (interpreters for 200+ languages), care consultations with dementia experts, local chapters, Community Resource Finder, ALZConnected online community.
- Alzheimer's Disease International (ADI)
Global federation of dementia associations in 100+ countries: member associations list, find local support, dementia information, World Alzheimer Report.
- Alzheimer's Drug Discovery Foundation
Funds the early work on new Alzheimer's medicines, in universities and companies.
Phone: 212.901.8000
- BrightFocus Foundation
US nonprofit that funds research and provides public information on Alzheimer's disease, macular degeneration and glaucoma.
- Dementia Alliance International (DAI)
Organisation for people with a dementia diagnosis: free online peer support groups, webinars, Brain Health Hub, resources for care partners.
- European Federation of Neurological Associations (EFNA)
Umbrella of 21 pan-European neurology patient groups; map of European neurology patient organisations.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Not medical advice. We show what is open and what is known; your care team decides what fits you.